Stroke caused by atherosclerosis of the major intracranial arteries

C Banerjee, MI Chimowitz - Circulation research, 2017 - Am Heart Assoc
Our goal in this review is to discuss the pathophysiology, diagnosis, and treatment of stroke
caused by atherosclerosis of the major intracranial arteries. References for the review were …

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment

CA Holmstedt, TN Turan, MI Chimowitz - The Lancet Neurology, 2013 - thelancet.com
Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high …

Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS …

P Gao, T Wang, D Wang, DS Liebeskind, H Shi, T Li… - Jama, 2022 - jamanetwork.com
Importance Prior randomized trials have generally shown harm or no benefit of stenting
added to medical therapy for patients with symptomatic severe intracranial atherosclerotic …

Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial

T Becske, DF Kallmes, I Saatci, CG McDougall… - Radiology, 2013 - pubs.rsna.org
Purpose To evaluate the safety and effectiveness of the Pipeline Embolization Device (PED;
ev3/Covidien, Irvine, Calif) in the treatment of complex intracranial aneurysms. Materials and …

[HTML][HTML] Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis

MI Chimowitz, MJ Lynn, H Howlett-Smith… - … England Journal of …, 2005 - Mass Medical Soc
Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke.
Warfarin is commonly used in preference to aspirin for this disorder, but these therapies …

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial

CP Derdeyn, MI Chimowitz, MJ Lynn, D Fiorella… - The Lancet, 2014 - thelancet.com
Background Early results of the Stenting and Aggressive Medical Management for
Preventing Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14 …

Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study

Y Wang, X Zhao, L Liu, YOY Soo, Y Pu, Y Pan, Y Wang… - Stroke, 2014 - Am Heart Assoc
Background and Purpose—We aimed to establish the prevalence, characteristics, and
outcomes of intracranial atherosclerosis (ICAS) in China by a large, prospective, multicenter …

Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical …

OO Zaidat, BF Fitzsimmons, BK Woodward, Z Wang… - Jama, 2015 - jamanetwork.com
Importance Intracranial stenosis is one of the most common etiologies of stroke. To our
knowledge, no randomized clinical trials have compared balloon-expandable stent …

Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results

RA Hanel, DF Kallmes, DK Lopes, PK Nelson… - Journal of …, 2020 - jnis.bmj.com
Background Preliminary clinical studies on the safety and efficacy of the pipeline
embolization device (PED) for the treatment of small/medium aneurysms have demonstrated …

Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial

B Jia, X Zhang, N Ma, D Mo, F Gao, X Sun… - JAMA …, 2022 - jamanetwork.com
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …